BR112022012998A2 - Composição e terapia para tratamento de reflexos faríngeos - Google Patents
Composição e terapia para tratamento de reflexos faríngeosInfo
- Publication number
- BR112022012998A2 BR112022012998A2 BR112022012998A BR112022012998A BR112022012998A2 BR 112022012998 A2 BR112022012998 A2 BR 112022012998A2 BR 112022012998 A BR112022012998 A BR 112022012998A BR 112022012998 A BR112022012998 A BR 112022012998A BR 112022012998 A2 BR112022012998 A2 BR 112022012998A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapy
- treatment
- composition
- pharyngeal
- reflexes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962954966P | 2019-12-30 | 2019-12-30 | |
| US17/100,677 US20210196748A1 (en) | 2019-12-30 | 2020-11-20 | Composition and therapy for treatment of gag reflexes |
| PCT/US2020/064604 WO2021138025A1 (en) | 2019-12-30 | 2020-12-11 | Composition and therapy for treatment of gag reflexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022012998A2 true BR112022012998A2 (pt) | 2022-09-06 |
Family
ID=76545400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022012998A BR112022012998A2 (pt) | 2019-12-30 | 2020-12-11 | Composição e terapia para tratamento de reflexos faríngeos |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US20210196748A1 (https=) |
| EP (1) | EP4084869A4 (https=) |
| JP (3) | JP7492772B2 (https=) |
| KR (1) | KR102671524B1 (https=) |
| AU (1) | AU2020417185B2 (https=) |
| BR (1) | BR112022012998A2 (https=) |
| WO (1) | WO2021138025A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210196748A1 (en) * | 2019-12-30 | 2021-07-01 | Robert Olson | Composition and therapy for treatment of gag reflexes |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB954241A (en) * | 1961-05-11 | 1964-04-02 | Koopmans Meelfabrieken N V | Process for the production of ready-for-use soups and sauces in powdered form |
| ZA73467B (en) * | 1972-02-25 | 1973-10-31 | Hoffmann La Roche | Mineral salts containing preparation |
| US4068006A (en) * | 1976-10-07 | 1978-01-10 | Akzona Incorporated | Salt seasoning mixture |
| US4414198A (en) * | 1982-04-23 | 1983-11-08 | Joseph Michaelson | Rapidly disintegrable tablet composition and method |
| US4634591A (en) * | 1985-09-06 | 1987-01-06 | Westerman Robert D | Anti-gagging compositions and method of treating gagging reflexes |
| DE10015662A1 (de) * | 2000-03-29 | 2001-10-04 | Henkel Kgaa | Zahnpflegemittel in Portionskapseln |
| US7799342B2 (en) * | 2000-12-06 | 2010-09-21 | Wyeth Llc | Fast dissolving tablet |
| US20050019277A1 (en) * | 2002-09-11 | 2005-01-27 | The Procter & Gamble Company | Tooth whitening products |
| US7989016B2 (en) * | 2006-10-05 | 2011-08-02 | Sambasiva Rao Chigurupati | Method for producing a low sodium salt composition |
| RU2345773C2 (ru) * | 2007-01-30 | 2009-02-10 | ФГУ Новосибирский научно-исследовательский институт травматологии и ортопедии (ФГУ ННИИТО Росздрава) | Способ ингаляционной анестезии с минимальным газотоком |
| US20120088971A1 (en) * | 2008-03-19 | 2012-04-12 | Hanu Surgical Devices Llc | ROTICAM: An Orotracheal Guide with Camera |
| CA2893780A1 (en) * | 2008-04-15 | 2009-10-22 | Trudell Medical International | Swallowing air pulse therapy mouthpiece and method for the use thereof |
| US10556011B2 (en) * | 2011-12-02 | 2020-02-11 | Joshua D. Levine | Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen |
| PL3473248T3 (pl) * | 2012-09-11 | 2022-07-25 | Norgine Bv | Kompozycje zawierające glikol polietylenowy i siarczany metali alkalicznych lub metali ziem alkalicznych do zastosowania jako kompozycje do oczyszczania jelita grubego |
| US20140335153A1 (en) * | 2013-05-09 | 2014-11-13 | Cure Pharmaceutical Corporation | Thin film with high load of active ingredient |
| EP3131433A1 (en) * | 2014-05-07 | 2017-02-22 | Colgate-Palmolive Company | Oral care system |
| US20160271120A1 (en) * | 2015-03-17 | 2016-09-22 | Oakdene Holdings Llc | Pharmaceutical composition for cleansing of the gastrointestinal tract |
| CN106420810A (zh) * | 2016-09-27 | 2017-02-22 | 天津市聚星康华医药科技有限公司 | 一种补液盐口腔溶解膜及其制备方法 |
| CN108354068A (zh) * | 2018-05-24 | 2018-08-03 | 张继成 | 一种多功能畜禽补水溶液及其制备方法 |
| US10857092B2 (en) | 2019-03-14 | 2020-12-08 | Glen D Lindbo | Avoiding gag reflex to enable swallowing pills |
| KR102245629B1 (ko) * | 2019-04-10 | 2021-04-30 | 주식회사 제네웰 | 히알루론산계 녹는 필름, 이의 제조방법 및 이에 사용되는 이형지 |
| US20210196748A1 (en) * | 2019-12-30 | 2021-07-01 | Robert Olson | Composition and therapy for treatment of gag reflexes |
| CN112042908A (zh) * | 2020-09-14 | 2020-12-08 | 湖南雨泉农业发展有限公司 | 一种无糖保健型葛粉果冻及其制作方法 |
-
2020
- 2020-11-20 US US17/100,677 patent/US20210196748A1/en not_active Abandoned
- 2020-12-11 AU AU2020417185A patent/AU2020417185B2/en active Active
- 2020-12-11 KR KR1020227025334A patent/KR102671524B1/ko active Active
- 2020-12-11 WO PCT/US2020/064604 patent/WO2021138025A1/en not_active Ceased
- 2020-12-11 EP EP20911237.4A patent/EP4084869A4/en active Pending
- 2020-12-11 JP JP2022539396A patent/JP7492772B2/ja active Active
- 2020-12-11 BR BR112022012998A patent/BR112022012998A2/pt not_active Application Discontinuation
-
2021
- 2021-05-07 US US17/315,164 patent/US11458162B2/en active Active
-
2022
- 2022-10-03 US US17/937,660 patent/US11701383B2/en active Active
- 2022-10-03 US US17/937,665 patent/US11813286B2/en active Active
-
2023
- 2023-09-11 US US18/244,734 patent/US20230414652A1/en active Pending
-
2024
- 2024-05-07 JP JP2024075398A patent/JP7724579B2/ja active Active
-
2025
- 2025-07-28 JP JP2025125856A patent/JP2025166003A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021138025A1 (en) | 2021-07-08 |
| AU2020417185B2 (en) | 2026-03-12 |
| JP2024105427A (ja) | 2024-08-06 |
| JP7492772B2 (ja) | 2024-05-30 |
| US20230025472A1 (en) | 2023-01-26 |
| JP2023516851A (ja) | 2023-04-21 |
| KR102671524B1 (ko) | 2024-05-31 |
| US11813286B2 (en) | 2023-11-14 |
| EP4084869A1 (en) | 2022-11-09 |
| US11701383B2 (en) | 2023-07-18 |
| AU2020417185A1 (en) | 2022-07-21 |
| US20210260105A1 (en) | 2021-08-26 |
| US20230024303A1 (en) | 2023-01-26 |
| US20230414652A1 (en) | 2023-12-28 |
| KR20220122680A (ko) | 2022-09-02 |
| US20210196748A1 (en) | 2021-07-01 |
| CA3163259A1 (en) | 2021-07-08 |
| EP4084869A4 (en) | 2024-02-14 |
| US11458162B2 (en) | 2022-10-04 |
| JP2025166003A (ja) | 2025-11-05 |
| JP7724579B2 (ja) | 2025-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125520T1 (el) | Μεθοδοι θεραπειας αμυλοειδωσης που διαμεσολαβειται με τρανσθυρετινη (ttr) | |
| BR112020017090A8 (pt) | Imunoterapias relacionadas com microbioma | |
| BR112015003188A2 (pt) | Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| BR112016020199A8 (pt) | composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso | |
| MX2021003905A (es) | Composicion de liberacion modificada de orlistat y acarbosa para el tratamiento de la obesidad y trastornos metabolicos relacionados. | |
| MX382162B (es) | Combinaciones farmacéuticas de un inhibidor de enzima hdac con un inhibidor de proteasoma, y su uso en el tratamiento de cáncer. | |
| MX2023014492A (es) | Compuestos utiles en la terapia para el vih. | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| ZA202002626B (en) | Use of riluzole prodrugs to treat ataxias | |
| MD4710B1 (ro) | Tratamente terapeutice pe bază de anamorelin | |
| BR112017016378A2 (pt) | composições da pró-droga de fumarato de monometila | |
| BR112018069682A2 (pt) | métodos de tratamento para doenças colestáticas e fibróticas | |
| PH12021550671A1 (en) | Prodrugs of cgrp antagonists | |
| BR112019005456A2 (pt) | composição farmacêutica e método para tratamento de esteatose hepática não alcoólica | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
| EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
| MX389282B (es) | Composiciones y métodos para tratar sinucleinopatías. | |
| BR112018007768A2 (pt) | composições e métodos para tratamento de homocistinúria | |
| BR112022012998A2 (pt) | Composição e terapia para tratamento de reflexos faríngeos | |
| ZA201906153B (en) | Pharmaceutical compositions for combination therapy | |
| CL2021000858A1 (es) | Derivados de 4-pirazin-2-ilmetil-morfolina y su uso como medicamento | |
| MX2022007738A (es) | Procesos e intermedios sinteticos. | |
| BR112017002449A2 (pt) | tratamento de sintomas associados com terapia de privação androgênica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |